Metabolism of drugs of abuse by cytochromes P450

Arthur K. Cho, Shizuo Narimatsu, Yoshito Kumagai

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Studies of most drugs of abuse utilize in vivo animal experimentation so that the responses measured reflect the pharmacokinetics of the administered drug as well as its pharmacodynamics. These drugs are generally lipid soluble chemicals and their elimination is dependent on metabolism, so an understanding of this process is critical to the interpretation of responses. This review summarizes the interaction between drugs of abuse and cytochromes P450, the oxidative enzymes that catalyze the first step of the metabolic process. Although they process their substrates by a common chemical mechanism, these enzymes differ markedly in their regulation, i.e. induction and inhibition, their substrate selectivities, the metabolites they generate and their relative concentration in different species. The activity of an enzyme catalyzing a specific metabolic reaction can be altered by prior xenobiotic exposure, by its genetics and by a co-administered drug, so that the pharmacokinetics of the drug under study can vary with the history of the individual subject. These issues are obviously important in human studies so, when possible, the relevant human enzymes involved in the processes described have been identified.

Original languageEnglish
Pages (from-to)283-301
Number of pages19
JournalAddiction Biology
Volume4
Issue number3
DOIs
Publication statusPublished - 1999

Fingerprint

Street Drugs
Cytochrome P-450 Enzyme System
Pharmaceutical Preparations
Enzymes
Pharmacokinetics
Xenobiotics
History
Lipids

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Cite this

Metabolism of drugs of abuse by cytochromes P450. / Cho, Arthur K.; Narimatsu, Shizuo; Kumagai, Yoshito.

In: Addiction Biology, Vol. 4, No. 3, 1999, p. 283-301.

Research output: Contribution to journalArticle

Cho, AK, Narimatsu, S & Kumagai, Y 1999, 'Metabolism of drugs of abuse by cytochromes P450', Addiction Biology, vol. 4, no. 3, pp. 283-301. https://doi.org/10.1080/13556219971498
Cho, Arthur K. ; Narimatsu, Shizuo ; Kumagai, Yoshito. / Metabolism of drugs of abuse by cytochromes P450. In: Addiction Biology. 1999 ; Vol. 4, No. 3. pp. 283-301.
@article{93826254cf4744608b0341eaab440e28,
title = "Metabolism of drugs of abuse by cytochromes P450",
abstract = "Studies of most drugs of abuse utilize in vivo animal experimentation so that the responses measured reflect the pharmacokinetics of the administered drug as well as its pharmacodynamics. These drugs are generally lipid soluble chemicals and their elimination is dependent on metabolism, so an understanding of this process is critical to the interpretation of responses. This review summarizes the interaction between drugs of abuse and cytochromes P450, the oxidative enzymes that catalyze the first step of the metabolic process. Although they process their substrates by a common chemical mechanism, these enzymes differ markedly in their regulation, i.e. induction and inhibition, their substrate selectivities, the metabolites they generate and their relative concentration in different species. The activity of an enzyme catalyzing a specific metabolic reaction can be altered by prior xenobiotic exposure, by its genetics and by a co-administered drug, so that the pharmacokinetics of the drug under study can vary with the history of the individual subject. These issues are obviously important in human studies so, when possible, the relevant human enzymes involved in the processes described have been identified.",
author = "Cho, {Arthur K.} and Shizuo Narimatsu and Yoshito Kumagai",
year = "1999",
doi = "10.1080/13556219971498",
language = "English",
volume = "4",
pages = "283--301",
journal = "Addiction Biology",
issn = "1355-6215",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Metabolism of drugs of abuse by cytochromes P450

AU - Cho, Arthur K.

AU - Narimatsu, Shizuo

AU - Kumagai, Yoshito

PY - 1999

Y1 - 1999

N2 - Studies of most drugs of abuse utilize in vivo animal experimentation so that the responses measured reflect the pharmacokinetics of the administered drug as well as its pharmacodynamics. These drugs are generally lipid soluble chemicals and their elimination is dependent on metabolism, so an understanding of this process is critical to the interpretation of responses. This review summarizes the interaction between drugs of abuse and cytochromes P450, the oxidative enzymes that catalyze the first step of the metabolic process. Although they process their substrates by a common chemical mechanism, these enzymes differ markedly in their regulation, i.e. induction and inhibition, their substrate selectivities, the metabolites they generate and their relative concentration in different species. The activity of an enzyme catalyzing a specific metabolic reaction can be altered by prior xenobiotic exposure, by its genetics and by a co-administered drug, so that the pharmacokinetics of the drug under study can vary with the history of the individual subject. These issues are obviously important in human studies so, when possible, the relevant human enzymes involved in the processes described have been identified.

AB - Studies of most drugs of abuse utilize in vivo animal experimentation so that the responses measured reflect the pharmacokinetics of the administered drug as well as its pharmacodynamics. These drugs are generally lipid soluble chemicals and their elimination is dependent on metabolism, so an understanding of this process is critical to the interpretation of responses. This review summarizes the interaction between drugs of abuse and cytochromes P450, the oxidative enzymes that catalyze the first step of the metabolic process. Although they process their substrates by a common chemical mechanism, these enzymes differ markedly in their regulation, i.e. induction and inhibition, their substrate selectivities, the metabolites they generate and their relative concentration in different species. The activity of an enzyme catalyzing a specific metabolic reaction can be altered by prior xenobiotic exposure, by its genetics and by a co-administered drug, so that the pharmacokinetics of the drug under study can vary with the history of the individual subject. These issues are obviously important in human studies so, when possible, the relevant human enzymes involved in the processes described have been identified.

UR - http://www.scopus.com/inward/record.url?scp=0032839602&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032839602&partnerID=8YFLogxK

U2 - 10.1080/13556219971498

DO - 10.1080/13556219971498

M3 - Article

VL - 4

SP - 283

EP - 301

JO - Addiction Biology

JF - Addiction Biology

SN - 1355-6215

IS - 3

ER -